本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dianthus Therapeutics Inc.

110.62
-0.4800-0.43%
成交量:27.26萬
成交額:2,994.20萬
市值:61.87億
市盈率:-26.90
高:111.28
開:110.08
低:105.05
收:111.10
52周最高:117.88
52周最低:22.81
股本:5,593.44萬
流通股本:5,586.51萬
量比:0.58
換手率:0.49%
股息:- -
股息率:- -
每股收益(TTM):-4.1130
每股收益(LYR):-4.2037
淨資產收益率:-26.07%
總資產收益率:-17.69%
市淨率:5.28
市盈率(LYR):-26.31

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/08/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]